Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 9, 1998, Pages 503-510

  Harima, Yoko ^a   Harima, Keizo ^a   Shikata, Nobuaki ^a   Oka, Atsutoshi ^a   Ohnishi, Takeo ^b   Tanaka, Yoshimasa ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bax; Bcl 2; Cervical carcinoma; Radiotherapy

Indexed keywords

DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION RESPONSE; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0031669402     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050206     Document Type: Article

References (46)

1. Apolinario RM, Valk P van der, Jong JS de, Deville W, Ark-Otte J van, Dingemans AM, Mourik JC van, Postmus PE, Pinedo HM, Giaccone G (1997) Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 15:2456-2466
2. Bauer H, Greer C, Manos M (1992) Detection of genital human papillomavirus infection using PCR. In: Herrington CS, McGee JO'D (eds) Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, pp 131-152
3. Britten RA, Evans AJ, Allalunis Turner MJ, Franko AJ, Pearcey RG (1996) Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol 39:145-153
4. Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser TC, Mihatsch MJ (1996) Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557-1565
5. Burger RA, Monk BJ, Kurosaki T, Anton Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18:association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88:1361-1368
6. Chang F, Syrjänen S, Syrjänen K (1995) Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13:1009-1022
7. Chen TM, Chen CA, Hsieh CY, Chang DY, Chen YU, Defendi V (1993) The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Oncogene 8:1511-1518
8. Chiou SK, Rao L, White E (1994) Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556-2563
9. Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NHA, Meyn RE (1996) Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 35:281-287
10. Diebold J, Baretton G, Felchner M, Meier W, Dopfer K, Schmidt M, Löhrs U (1996) Bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas. Am J Clin Pathol 105:341-349
11. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 6:363-370
12. Falkvoll KH, Real C (1991) Quantitative histological changes in a human melanoma xenograft following exposure to single dose irradiation and hyperthermia. Int J Radiat Oncol Biol Phys 21:989-994
13. FIGO (international Federation of Gynecology and Obstetrics) (1979)Annual Report on the results of treatment in carcinoma of the uterus, vagina, and ovary, vol 16. Radiumhemmet, Sweden FIGO
14. Gasinska A, Zabaglo L, Cichocka A (1995) Micronucleus assay in three transplantable mouse tumors. Neoplasma 42:243-248
15. Gazzaniga P, Gradilone A, Vercillo R, Gandini O, Silvestri I, Napolitano M, Albonici L, Vincenzoni A, Gallucci M, Frati L, Agliano AM (1996) Bcl-2/bax mRNA expression ratio as a prognostic factor in low-grade urinary bladder cancer. Int J Cancer 69:100-104
16. Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-223
17. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097
18. Hanada M, Aimé-Sempé C, Sato T, Reed JC (1995) Structure-function analysis of the Bcl-2 protein. J Biol Chem 270:11962-11968
19. Harima Y, Harima K, Hasegawa T, Shikata N, Tanaka Y (1996) Transcatheter arterial embolization with Cisplatin: Apoptosis in VX2 tumor uterus transplants. Anticancer Res 16:193-199
20. ICRU Report 38 (1985). Dose and volume specification for reporting intracavitary therapy in gynecology. International Commision of Radiation Units and Measurements, Bethesda, MD, pp 1-16
21. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
22. Kapp DS, Giaccia A (1996) New direction for radiation biology research in cancer of the uterine cervix. J Natl Cancer Inst 21:131-138
23. Kasten M, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311
24. Kawana T (1995) Human papilloma virus and cervical cancer. Jpn J Cancer Chemother 22:711-717
25. Koshida Y, Saegusa M, Okayasu I (1997) Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 75:367-373
26. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-1714
27. Kristensen GB, Karlsen F, Jenkins A, Kaern J, Abeler VM, Trope CG (1996) Human papilloma virus has no prognostic significance in cervical carcinoma. Eur J Cancer 32A:1349-1353
28. Lipponen P, Pietiläinen T, Kosma VM, Aaltomaa S, Eskelinen M, Syrjänen K (1995) The apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with a favourable prognosis. J Pathol 177:49-55
29. Lipponen PK, Aaltomaa S, Eskelinen M (1996) Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours. Histopathology 28:135-140
30. Lowe SW, Schmitt EM, Smith SW, Osborne BA (1993) p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362:847-849
31. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810
32. Macklis RM, Lin JY, Beresford B, Atcher RW, Hines JJ, Humm JL (1992) Cellular kinetics, dosimetry, and radiobiology of α-particle radioimmunotherapy: induction of apoptosis. Radiat Res 130:220-226
33. Matsumoto K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T (1997) Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females. Jpn J Cancer Res 88:369-375
34. Nakano T, Oka K, Taniguchi N (1996) Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 56:2771-2775
35. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619
36. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP (1994) p53 mutations in HPV-negative cervical carcinoma. Oncogene 9: 205-210
37. Pezzella F, Tso AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncoprotein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232
38. Pontén J, Adami HO, Bergström R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparén P, Trichopoulos D (1995) Strategies for global control of cervical cancer. Int J Cancer 60:1-26
39. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6
40. Sinicrope FA, Ruan S, Cleary KR, Stephens LC, Lee JJ, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
41. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA (1996) Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122:627-632
42. Stephen LC, Ang KK, Schultheiss TE, Milas L, Meyn R (1991) Apoptosis in irradiated murine tumors. Radiat Res 127:308-316
43. Toita T, Nakano M, Higashi M, Sakamoto K, Kanazawa K (1995) Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys 15:843-849
44. Virostek LJ, Kim RY, Spencer SA, Meredith RF, Jennelle RL, Soong SJ, Salter MM (1996) Postsurgical recurrent carcinoma of the cervix: reassessment and results of radiation therapy options. Radiology 201:559-563
45. West CML, Davidson SE, Roberts SA, Hunter RD (1993) Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer 68:819-823
46. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A (1990) Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers. Int J Cancer 45:990-992